Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern

Taishi Kondo; Kazuhiro Matsuoka; Shun Umemoto; Tomoshige Fujino; Gosuke Hayashi; Yasumasa Iwatani; Hiroshi Murakami

doi:10.26508/lsa.202101322

Research Article

Open Access

Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern

View ORCID ProfileTaishi Kondo, View ORCID ProfileKazuhiro Matsuoka, View ORCID ProfileShun Umemoto, Tomoshige Fujino, Gosuke Hayashi, View ORCID ProfileYasumasa Iwatani Correspondence email, View ORCID ProfileHiroshi Murakami Correspondence email

Taishi Kondo

1Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Japan

Roles: Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, review, and editing

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Taishi Kondo

Kazuhiro Matsuoka

2Department of Infectious Diseases and Immunology, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Roles: Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, review, and editing

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kazuhiro Matsuoka

Shun Umemoto

1Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Japan

Roles: Resources, Data curation, Formal analysis, Validation, Visualization, Writing—original draft, review, and editing

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Shun Umemoto

Tomoshige Fujino

1Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Japan

Roles: Funding acquisition, Writing—original draft, review, and editing

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gosuke Hayashi

1Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Japan

3Japan Science and Technology Agency (JST), PRESTO, Kawaguchi, Japan

Roles: Funding acquisition, Writing—original draft, review, and editing

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yasumasa Iwatani

2Department of Infectious Diseases and Immunology, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan

4Division of Basic Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan

Roles: Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing—original draft, review, and editing

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yasumasa Iwatani
For correspondence: iwatani.yasumasa.cp@mail.hosp.go.jp

Hiroshi Murakami

1Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Japan

5Institute of Nano-Life-Systems, Institutes of Innovation for Future Society, Nagoya University, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hiroshi Murakami
For correspondence: murah@chembio.nagoya-u.ac.jp

Published 7 March 2022. DOI: 10.26508/lsa.202101322

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

You are using an old browser, click here to download PDF

PDF Container

PreviousNext

Download PDF

Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern

Message Subject (Your Name) has sent you a message from Life Science Alliance

Message Body (Your Name) thought you would like to see the Life Science Alliance web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Potent SARS-CoV-2-neutralizing monobody

Taishi Kondo, Kazuhiro Matsuoka, Shun Umemoto, Tomoshige Fujino, Gosuke Hayashi, Yasumasa Iwatani, Hiroshi Murakami

Life Science Alliance Mar 2022, 5 (6) e202101322; DOI: 10.26508/lsa.202101322

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Potent SARS-CoV-2-neutralizing monobody

Taishi Kondo, Kazuhiro Matsuoka, Shun Umemoto, Tomoshige Fujino, Gosuke Hayashi, Yasumasa Iwatani, Hiroshi Murakami

Life Science Alliance Mar 2022, 5 (6) e202101322; DOI: 10.26508/lsa.202101322

Share This Article:

Tweet Widget
Facebook Like

In this Issue

Volume 5, No. 6

June 2022

Table of Contents
Cover (PDF)
About the Cover
Masthead (PDF)

Jump to section

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

Subjects

Microbiology, Virology & Host Pathogen Interaction

No related articles found.

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern

Citation Manager Formats

In this Issue

Subjects

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Content

For Authors

Other Services

More Information